In addition, SQR1-CQ exhibited significantly higher fluorescence, when compared to a 
Introduction

35
Malaria is a deadly disease caused by the protozoan parasite Plasmodium falciparum that affects 36 resource-limited regions such as Africa and South-east Asia [1] . Chloroquine (CQ) was the drug of 37 choice against malaria due to its clinical effectiveness and low-cost. However, mutations within the 38 parasite quickly gave rise to CQ resistance and CQ was taken off the arsenal of frontline drugs 39 against malaria [2] . In recent years, several groups were focusing on resolving the problem of CQ 40 resistance in malaria, such as by seeking ways towards new uses of CQ in practical applications 41 against malaria [2] [3] [4] [5] . Some of these novel approaches involve modification of CQ and related 
48
(ii) 5N HCl, AcOH/H2O (1:1), reflux, 2 h; (iii) n-BuOH/toluene (4:1); reflux; 3 h. 
63
In this study, building on this important finding, we herein designed and synthesized 2 64 squaraine NIR dyes SQR1 and SQR2, and explored their application. The dyes were then interesting to note that by using a basic hydrolysis of Na t OBu in THF instead of acid hydrolysis, the 81 -(CH2)2CO2Bu attached to the indolium was cleaved. This dye candidate, when embedded within 82 folic acid functionalized liposome membrane, could be used as ovarian cancer cells bioimaging [25] .
83
The presence of the carboxylic group is an important design for further functionalization of the 84 squaraine NIR dyes. In this report, the squaraine dyes were coupled with chloroquine to serve as a 85 malaria diagnostic probe, which is depicted in Scheme 2. 5 was synthesized from known method
86
[26], and reacted readily with Boc protected 6 [27] to give modified CQ 7. By combining either SQR1 87 or SQR2 to CQ 7, SQR1-CQ or SQR2-CQ were formed via amide bond coupling using HATU. 
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Although other fluorescent compounds have been synthesized and assessed for labelling of P.
101
falciparum towards diagnostics applications, the groups behind these reports had either only used 102 CQ-sensitive P. falciparum strains [28] or Plasmodium species that is not known to infect humans [29] . 
119
We then proceeded to perform SQR1-CQ labelling on CQ-resistant P. falciparum strains, 7G8 
IC50 Studies
181
The conjugation of SQR1 to CQ has provided renewed application value for CQ, in light of high 182 resistance to CQ in malaria worldwide. In this context, we made the unexpected finding from 183 reinvasion assays to calculate IC50 values of SQR1-CQ, that the IC50 of SQR1-CQ against resistant 184 strain K1 is almost 10-fold lower than that of untagged CQ against K1. This is in contrast to the 185 increase in IC50 of SQR1-CQ against sensitive strain 3D7, compared to the IC50 of CQ against 3D7.
186
While these findings go against the general trend of antimalarial activity of CQ against 3D7 and K1
187
[1], it is to be noted that the IC50 of SQR1-CQ against 3D7 is similar to that reported by Loh et al. for 
209
Co-localisation of SQR1-CQ and Hoechst 33342 in 3D7 parasites (arrowheads). Bar = 10 µm.
210
Fluorescence labelling to complement the "gold standard" light microscopy methods have been microscopy. In addition to SQR1-CQ labelling of P. falciparum parasites in suspension, we have also,
214
for the first time, demonstrated directly visible SQR1-CQ and Hoechst co-labelling of P. 
218
Besides the promising re-purpose of CQ from an antimalarial to diagnostic tool, further steps 219 could be done to integrate SQR1-CQ into the LED fluorescence microscopy methodology, given the 220 reported field feasibility of LED fluorescence microscopy, usability in daytime, point-of-care 
262
SQR1-CQ:
To a solution of 7 (44.8 mg, 0.11 mmol) in 3 mL of CH2Cl2, TFA (8.5 µL, 0.11 mmol)
263
was added at 0 o C and allowed to stir at room temperature for 3 h. After which, the mixture was 
Fluorescence Labelling of Unfixed Thin Smear Preparations
304
To perform dual-labelling of SQR1-CQ and Hoechst 33342, 3D7 P. falciparum cultures at 3% 
Conclusions
334
In the present study, we have designed and synthesized a squaraine NIR dye, which is 335 functionalized with chloroquine. Our assessment of the squaraine dye-CQ conjugate, SQR1-CQ,
336
demonstrates that CQ, an antimalarial with greatly diminished therapeutic efficacy against P. 
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